Can She Take Ashwagandha with Buspirone?
Yes, she can likely take ashwagandha with buspirone, as there is no documented pharmacokinetic interaction between these agents, but monitor for additive sedation and serotonergic effects, and be aware of ashwagandha's emerging hepatotoxicity concerns.
Pharmacokinetic Interaction Assessment
The primary concern with buspirone drug interactions involves CYP3A4 inhibitors and inducers, as buspirone is extensively metabolized by this enzyme 1. Recent research specifically evaluated ashwagandha's effect on cytochrome P450 enzymes and found no reversible inhibition at IC50 > 100 μg/mL extract for CYP3A4 and other major P450 enzymes 2. This suggests ashwagandha is unlikely to significantly alter buspirone metabolism through this pathway.
Pharmacodynamic Considerations
While pharmacokinetic interactions appear minimal, consider these pharmacodynamic factors:
Serotonergic effects: Buspirone acts on serotonin receptors 1, and while ashwagandha's mechanism differs (primarily adaptogenic/GABAergic), there is theoretical concern for additive effects. One case report documented hypomania when combining buspirone with herbal medicines (St. John's Wort and Ginkgo biloba), though this involved known serotonergic herbs 3.
Sedation potential: Both agents can cause CNS effects. Buspirone commonly causes dizziness (most frequent adverse event) 4, and ashwagandha may cause drowsiness 5, 6.
Critical Safety Warnings
Hepatotoxicity Risk with Ashwagandha
This is the most important clinical consideration. Recent evidence reveals ashwagandha-associated liver injury is an emerging concern:
- A 2026 scoping review identified 25 cases of ashwagandha-associated liver injury globally, typically presenting as cholestatic or mixed hepatitis after weeks of use 7
- Severe outcomes included one acute liver failure requiring transplantation and three deaths in patients with pre-existing cirrhosis 7
- Patients with any chronic liver disease should avoid ashwagandha 7
Clinical action: Obtain baseline liver function tests before starting ashwagandha, and monitor ALT/AST if used chronically. Counsel patients to discontinue immediately if jaundice or pruritus develops.
Buspirone-Specific Warnings
From the FDA label 1:
- Contraindicated with MAOIs (14-day washout required)
- Serotonin syndrome risk when combined with other serotonergic agents
- Monitor for suicidal ideation, particularly during initiation 4
Practical Recommendations
If proceeding with combination therapy:
Start conservatively: Use standard buspirone dosing (5 mg TID initially) 8 and typical ashwagandha doses (300 mg twice daily) 5, 6
Monitor for:
- Excessive sedation or dizziness
- Signs of serotonin syndrome (agitation, tremor, hyperthermia, GI symptoms)
- Hepatotoxicity (jaundice, pruritus, RUQ pain)
Avoid if:
- Pre-existing liver disease (absolute contraindication for ashwagandha)
- Concurrent use of other serotonergic medications
- Taking strong CYP3A4 inhibitors (diltiazem, verapamil, erythromycin, itraconazole) with buspirone 1
Timing consideration: Ashwagandha is typically taken with food; buspirone should be taken consistently either with or without food 1
Common Pitfalls to Avoid
- Don't assume "natural" means safe: Ashwagandha has documented hepatotoxic potential 7, 9
- Don't overlook supplement quality: Ashwagandha products vary widely in standardization and may contain contaminants 9
- Don't forget to assess for polypharmacy: Both agents have multiple drug interactions that compound risk 1, 2